Literature DB >> 5673225

Eleven-year follow-up of a patient with malignant hypertension secondary to pyelonephritis and renal insufficiency.

T Mawar, J M Rojo-Ortega, J Genest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5673225      PMCID： PMC1924322     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Effects of antihypertensive treatment on the evolution of the renal lesions in malignant nephrosclerosis.

Authors:  L J McCORMACK; J E BELAND; R E SCHNECKLOTH; A C CORCORAN
Journal:  Am J Pathol       Date:  1958 Nov-Dec       Impact factor: 4.307

2.  Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

Authors:  M HARINGTON; P KINCAID-SMITH; J McMICHAEL
Journal:  Br Med J       Date:  1959-11-14

3.  The effect of treatment on the vascular deterioration associated with hypertension, with particular emphasis on renal function.

Authors:  J H MOYER; C HEIDER; K PEVEY; R V FORD
Journal:  Am J Med       Date:  1958-02       Impact factor: 4.965

4.  The choice of drugs and the management of essential hypertension.

Authors:  M Sokolow; D Perloff
Journal:  Prog Cardiovasc Dis       Date:  1965-11       Impact factor: 8.194

5.  Treatment of malignant hypertension.

Authors:  C T Dollery
Journal:  Mod Treat       Date:  1966-01
  5 in total
  1 in total

1.  Screening programs for hypertension.

Authors:  J Genest; O Kuchel; G Leduc; P Granger; R Boucher; J M Rojo-Ortega; W Nowaczynski
Journal:  Can Med Assoc J       Date:  1974-07-20       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.